News

Nienke Verstegen, researcher at De Forensische Zorgspecialisten, has conducted research on aggression within forensic care and its impact on patients and staff. On July 6, 2023, she will receive her PhD from Maastricht University with her dissertation 'Hurt people hurt people. Characteristics and...

Patients admitted to hospital due to a severe COVID-19 infection exhibit no evidence of brain damage caused by the disease. This is the conclusion of an extensive study led by Maastricht University.

Due to the Western lifestyle with a high fat diet combined with little exercise, more and more people in the Netherlands are overweight or even obese. This causes an increased risk of type II diabetes. What can be done about this besides a healthier lifestyle? The answer comes from an unexpected...

Survivors of colon cancer often have symptoms associated with the cancer or treatment for years after treatment, such as fatigue and tingling in fingers and feet. This has a great impact on the perceived quality of life. Whereas current lifestyle advice is mainly aimed at prevention of (colon)...

Astrid Meesters received her doctorate on Sept. 28 with her PhD research on flexibility and mindfulness as resilience factors for pain and recovery. 

In his PhD research, Kristof Vandael investigated how this generalization of pain-related avoidance can be inhibited in the lab to help optimize therapy for chronic pain or even prevent the development of chronic pain.

Prof. Dr. Leentjens at Maastricht University has been researching the relationship between psychiatric and neurological symptoms for years in order to pay more attention to mental symptoms in treatment.

In honour of the presentation of the VNVA Els Borst Prize for her oeuvre, Prof Marlies Bongers is organising the symposium "menstruation in RED on the agenda" on 1 October.

In women trying to conceive, 1-3% experience repeated miscarriages. For more than 50% of these women, a cause for the miscarriages has yet to be found. New research from Maastricht University (UM) and the Maastricht University Medical Centre+ (MUMC+) shows that the immune system’s Natural Killer (NK...

The European Commission has awarded €23 million to set up a new platform for drug repurposing: the use of existing drugs in diseases other than those for which they were originally developed. In the next seven years UM will develop the platform REPO4EU (precision drug REPurpOsing for Europe)...